STOCK TITAN

CANNABIS BIOSCI INTL HLDG - $CBIH STOCK NEWS

Welcome to our dedicated page for CANNABIS BIOSCI INTL HLDG news (Ticker: $CBIH), a resource for investors and traders seeking the latest updates and insights on CANNABIS BIOSCI INTL HLDG stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANNABIS BIOSCI INTL HLDG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANNABIS BIOSCI INTL HLDG's position in the market.

Rhea-AI Summary

Cannabis Bioscience International Holdings (CBIH) has appointed Mr. John E. Jones as its new Treasurer and Director. Mr. Jones brings a wealth of experience from his successful career in the business sector, with a focus on strategic acquisitions, mergers, and capital projects. His expertise is expected to bolster CBIH's position in the cannabis industry, particularly in cannabinoid research and innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) initiates a clinical trial for Orthocann, a new intra-articular cannabinoid-based injection for knee osteoarthritis. The company aims to assess its efficacy in treating knee cartilage damage and providing relief without the adverse effects of corticosteroid injections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) announces the retirement of one billion shares by its CEO, Dante Picazo, contributing to a reduction in outstanding shares to approximately 9.4 billion. The market price of the shares is valued at $5 million, aiming to increase shareholder value. This move follows previous contributions by current management, totaling 5.5 billion shares since 2019, without a reverse stock split. The Company's commitment to innovation in medical formulations and biotechnology, supported by AI algorithms, reflects a focus on market integrity and scientific research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) appoints Brian Cuban as Advisory Board Member, bringing legal, corporate leadership, and mental health expertise. Cuban, brother of Mark Cuban, is a lawyer, author, and advocate with a history of recovery. His addition aims to enhance CBIH's mission of advancing cannabinoid medicine and improving patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
management
-
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) partners with Bull in Advantage for Investor Relations services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) CEO Dante Picazo sends a letter to shareholders, highlighting the company's progress in developing formulations for various medical conditions, including osteoarthritis and depressive disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) achieved SEC effectiveness for its Form S-1 registration statement, aiming to start its own cannabis clinical trials using AI programs to optimize research processes and acquire clinical evidence for its intellectual property cannabinoid formulations. The company plans to treat cancer, PTSD, COVID-19, Herpes Zoster, chronic pain, and other conditions. CBIH is dedicated to representing Texas as a leader in the medicinal cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) announces the declaration of its registration statement on Form S-1, filed under the Securities Act of 1933, as effective by the SEC. The company is offering 10,087,154,885 shares of its common stock at a price of $0.0008 per share, with 6,250,000,000 shares offered by the company and the remaining 3,837,154,885 shares by selling stockholders. The company has become a reporting company under Section 15(d) of the Securities Exchange Act of 1934, required to file annual, quarterly, and other reports with the SEC. The company offers services in clinical trials and cannabis-related education, intending to conduct clinical trials of its own cannabidiol products and sell them.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings launches new website as part of rebranding strategy, emphasizing research and production of cannabis as medicine. The website provides information on future plans and invites qualified investors to review projects. Contact ir@cbih.net for more information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Cannabis Bioscience International Holdings gets approval for name and ticker symbol change
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
CANNABIS BIOSCI INTL HLDG

OTC:CBIH

CBIH Rankings

CBIH Stock Data

6.78M
5.64B
39.71%
Other Crushed and Broken Stone Mining and Quarrying
Mining, Quarrying, and Oil and Gas Extraction
Link
United States of America
Houston

About CBIH

chnc is committed to connecting with the public through information, education and knowledge. we thrive with passion, integrity, diversity and globalization.